Search Results - "Bakowska, E"

Refine Results
  1. 1

    High frequency of neurosyphilis in HIV‐positive patients diagnosed with early syphilis by Firlag‐Burkacka, E, Swiecki, P, Cielniak, I, Siwak, E, Gizinska, J, Bakowska, E, Kubicka, J, Pulik, P, Kowalski, J, Podlasin, R, Horban, A

    Published in HIV medicine (01-05-2016)
    “…Background Syphilis is an infection frequently seen with HIV, and European guidelines on the management of syphilis suggest that HIV‐infected patients may have…”
    Get full text
    Journal Article
  2. 2

    Demographic and HIV‐specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial by Sharma, S, Babiker, AG, Emery, S, Gordin, FM, Lundgren, JD, Neaton, JN, Bakowska, E, Schechter, M, Wiselka, MJ, Wolff, MJ

    Published in HIV medicine (01-04-2015)
    “…Objectives The risks and benefits of initiating antiretroviral treatment (ART) at high CD4 cell counts have not been reliably quantified. The Strategic Timing…”
    Get full text
    Journal Article
  3. 3

    Saquinavir/r containing initial antiretroviral therapy (ART)-long term evaluation in Polish Observational Cohort of HIV/AIDS Patients (POLCA) Study Group by Kubicka, J, Ignatowska, A, Kowalska, J.D, Cielniak, I, Pulik, P, Bakowska, E, Chylak, A, Burkacka Firlag, E, Horban, A

    Published in HIV & AIDS review (01-01-2015)
    “…Abstract Background Since the introduction of highly active antiretroviral treatment significant decrease of HIV related morbidity and mortality has been…”
    Get full text
    Journal Article
  4. 4

    Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population by RODGER, Alison J, LODWICK, Rebecca, SCHECHTER, Mauro, DEEKS, Steven, AMIN, Janaki, GILSON, Richard, PAREDES, Roger, BAKOWSKA, Elzbieta, ENGSIG, Frederik N, PHILLIPS, Andrew

    Published in AIDS (London) (27-03-2013)
    “…Due to the success of antiretroviral therapy (ART), it is relevant to ask whether death rates in optimally treated HIV are higher than the general population…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe by Sandri, Anastasia Karachalia, Rodger, Alison, Benfield, Thomas, Milinkovic, Ana, Stellbrink, Hans‐Jürgen, Sambatakou, Helen, Caldeira, Luis, Laguno, Monserrat, Gisinger, Martin, Rockstroh, Jürgen Kurt, Mocroft, Amanda, Losso, M, Kundro, M, Schmied, B, Vassilenko, A, Mitsura, VM, Wit, S De, Vandekerckhove, L, Begovac, J, Jilich, D, Sedlacek, D, Kronborg, G, Benfield, T, Katzenstein, T, Pedersen, C, Moller, NF, Nielsen, L N, Zilmer, K, Viard, J‐P, Girard, P‐M, Fontas, E, Behrens, G, Fätkenheuer, G., Sambatakou, H, Szlávik, J, Gottfredsson, M, Devitt, E, Hassoun, G, Elinav, H, Haouzi, M, Esposito, R, Mussini, C, Mazzotta, F, Ridolfo, A, Staub, T, Hemmer, R, Dragas, S, Reiss, P, Reikvam, DH, Gasiorowski, J, Inglot, M, Mozer‐Lisewska, I, Rozplochowski, B, Mansinho, K, Oprea, C, Davila, Carol, Yakovlev, A, Blokhina, I.N., Novogrod, Nizhny, Borodulina, E, Ranin, J, Tomazic, J, Miró, JM, Martinez, E, Martinez‐Rebollar, M, Mallolas, J, Clotet, B, Jou, A, Llibre, JM, Gutierrez, M, Mateo, G, Falconer, K, Flamholc, L, Cavassini, M, Battegay, M, Schmid, P, Milinkovic, A, Johnson, AM, Simons, E, Edwards, S, Mocroft, A, Leen, C, Karpov, I, Aho, I, Svedhem, V, Pradier, C, Chkhartishvili, N, Kowalska, JD, Wandeler, G, Paredes, R, Kirk, O, Peters, L, Bojesen, A, Raben, D, Hansen, EV, Larsen, JF, Cozzi‐Lepri, A, Pelchen‐Matthews, A, Roen, A, Reekie, J

    Published in HIV medicine (01-07-2022)
    “…Objectives Although direct‐acting antivirals (DAAs) can clear HCV in nearly all HIV/HCV‐coinfected individuals, high rates of reinfection may hamper efforts to…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Establishing a hepatitis C continuum of care among HIV/hepatitis C virus‐coinfected individuals in EuroSIDA by Peters, L, Sluzhynska, M, Scherrer, A, Domingo, P, Gerstoft, J, Viard, JP, Leen, C, Jablonowska, E, Wandeler, G, Falconer, K, D'Arminio Monforte, A, Rockstroh, JK, Lundgren, JD, Mocroft, A, Kundro, M, Schmied, B, Paduto, D, Clumeck, N, De Wit, S, Vandekerckhove, L, Johansen, IS, Wiese, L, Moller, NF, Aho, I, Pradier, C, Bogner, J, Xylomenos, G, Armenis, K, Sambatakou, H, Szlávik, J, Mulcahy, F, Yust, I, Burke, M, Hassoun, G, Elinav, H, Haouzi, M, Elbirt, D, Sthoeger, ZM, Esposito, R, Mazzotta, F, Vullo, V, Antinori, A, Acinapura, R, Plazzi, M, Castagna, A, Gianotti, N, Rozentale, B, Uzdaviniene, V, Staub, T, Reikvam, DH, Bruun, J, Gasiorowski, J, Bakowska, E, Parczewski, M, Beniowski, M, Smiatacz, T, Wojcik, K, Caldeira, L, Mansinho, K, Maltez, F, Radoi, R, Trofimora, T, Khromova, I, Kuzovatova, E, Borodulina, E, Jevtovic, D, Tomazic, J, Laguno, M., Martinez, E., Garcia, F., Martinez‐Rebollar, M., Moreno, S, Rodriguez, JM, Clotet, B, Paredes, R, Puig, J, Gutierrez, M, Mateo, G, Treutiger, CJ, Flamholc, L, Weber, R, Furrer, H, Schmid, P, Kuznetsova, A, Kyselyova, G, Gazzard, B, Johnson, AM, Simons, E, Edwards, S, Phillips, A, Weber, J, Clarke, A, Svedhem, V, Kowalska, JD, Guaraldi, G, Kirk, O, Bojesen, A, Raben, D, Laut, K, Nykjær, B

    Published in HIV medicine (01-04-2019)
    “…Objectives The aim of the study was to establish a methodology for evaluating the hepatitis C continuum of care in HIV/hepatitis C virus (HCV)‐coinfected…”
    Get full text
    Journal Article
  12. 12

    The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people by Shepherd, L, Bower, M, Silverberg, M, Ristola, M, Mussini, C, Mansinho, K, Yust, I, Paduta, D, Jilich, D, Smiatacz, T, Tomazic, J, Plomgaard, P, Lundgren, J, Mocroft, A, Schmied, B, Paduto, D, Clumeck, N, De Wit, S, Vandekerckhove, L, Machala, L, Gerstoft, J, Ostergaard, L, Wiese, L, Zilmer, K, Jelena Smidt, Ristola, M, Duvivier, C, Rockstroh, J, Degen, O, Stellbrink, HJ, Stefan, C, Sambatakou, H, Mulcahy, F, Turner, D, Burke, M, Shahar, E, Elbirt, D, D'Arminio Monforte, A, Esposito, R, Mazeu, I, Vullo, V, Lichtner, M, Antinori, A, Lazzarin, A, Castagna, A, Gianotti, N, Galli, M, Matulionyte, R, Reiss, P, Knysz, B, Gasiorowski, J, Bakowska, E, Flisiak, R, Maciejewska, K, Aksak‐Was, B, Beniowski, M, Mularska, E, Gensing, M, Jablonowska, E, Malolepsza, E, Wojcik, K, Maltez, F, Oprea, C, Panteleev, O, Yakovlev, A, Kuzovatova, E, Borodulina, E, Jevtovic, D, Gatell, JM, Miró, JM, Moreno, S, Clotet, B, Sambeat, MA, Laporte, JM, Sonnerborg, A, Blaxhult, A, Scherrer, A, Cavassini, M, Calmy, A, Furrer, H, Schmid, P, Kuznetsova, A, Sluzhynska, M, Simons, E, Edwards, S, Johnson, MA, Orkin, C, Scullard, G, Gatell, J, Gazzard, B, Horban, A, d'Arminio Monforte, A, Rockstroh, J, Rockstroh, J, Kirk, O, Kirk, O, Fischer, AH, Bojesen, A, Raben, D, Kristensen, D

    Published in HIV medicine (01-02-2018)
    “…Objectives B‐cell dysfunction and activation are thought to contribute to lymphoma development in HIV‐positive people; however, the mechanisms are not well…”
    Get full text
    Journal Article
  13. 13

    Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe by Santos, JR, Cozzi‐Lepri, A, Phillips, A, De Wit, S, Pedersen, C, Lazzarin, A, Sluzhynska, M, Orkin, C, Duvivier, C, Bogner, J, Gargalianos‐Kakolyris, P, Schmid, P, Hassoun, G, Khromova, I, Beniowski, M, Sedlacek, D, Paredes, R, Lundgren, JD, Losso, M, Zangerle, R, Vassilenko, A, Paduto, D, Clumeck, N, Delforge, M, Florence, E, Vandekerckhove, L, Begovac, J, Machala, L, Jilich, D, Benfield, T, Ostergaard, L, Ristola, M, Viard, J.‐P, Girard, P.‐M, Rockstroh, J, Schmidt, R, Degen, O, Stellbrink, H. J, Stefan, C, Sambatakou, H, Szlávik, J, Mulcahy, F, Yust, I, Sthoeger, Z. M, D'Arminio Monforte, A, Mussini, C, Mazzotta, F, Vullo, V, Zaccarelli, M, Antinori, A, Acinapura, R, Plazzi, M, Gianotti, N, Galli, M, Ridolfo, A, Matulionyte, R, Staub, T, Bruun, J, Gasiorowski, J, Pynka, M, Mularska, E, Gensing, M, Jablonowska, E, Mansinho, K, Maltez, F, Radoi, R, Panteleev, A, Panteleev, O, Trofimora, T, Borodulina, E, Vdoushkina, E, Gatell, J. M, Moreno, S, Rodriguez, J. M, Clotet, B, Tural, C, Puig, J, Bravo, I, Mateo, G, Sambeat, M. A, Thalme, A, Cavassini, M, Calmy, A, Furrer, H, Battegay, M, Kuznetsova, A, Kyselyova, G, Simons, E, Edwards, S, Johnson, M. A, Mocroft, A, Weber, J, Clarke, A, Gatell, J, Matthews, C, Fischer, A. H, Raben, D, Grønborg Laut, K, Larsen, J. F, Schultze, A

    Published in HIV medicine (01-05-2018)
    “…Objectives The aim of the study was to evaluate the long‐term response to antiretroviral treatment (ART) based on atazanavir/ritonavir (ATZ/r)‐,…”
    Get full text
    Journal Article
  14. 14

    Demographic and HIV ‐specific characteristics of participants enrolled in the INSIGHT S trategic T iming of AntiRetroviral T reatment ( START ) trial by Sharma, S, Babiker, AG, Emery, S, Gordin, FM, Lundgren, JD, Neaton, JN, Bakowska, E, Schechter, M, Wiselka, MJ, Wolff, MJ

    Published in HIV medicine (01-04-2015)
    “…Objectives The risks and benefits of initiating antiretroviral treatment ( ART ) at high CD 4 cell counts have not been reliably quantified. The S trategic T…”
    Get full text
    Journal Article
  15. 15

    Corneal perforation requiring corneal grafting: a rare complication of gonococcal eye infection by Tipple, Craig, Smith, Alan, Bakowska, Elzbieta, Corbett, Melanie C

    Published in Sexually transmitted infections (01-11-2010)
    “…The authors present a case of severe gonococcal conjunctivitis associated with corneal perforation of the right eye in a 25-year-old homosexual man. Inpatient…”
    Get more information
    Journal Article
  16. 16

    Fatal and nonfatal AIDS and non-AIDS events in HI V-1-positive individuals with high CD4 cell counts according to viral load strata by Reekie, J, Gatell, J M, Yust, I, Bakowska, E, Rakhmanova, A, Losso, M, Krasnov, M, Francioli, P, Kowalska, J D, Mocroft, A

    Published in AIDS (London) (01-01-2011)
    “…Background: This study compared the incidence of fatal and nonfatal AIDS and non-AIDS events in HIV-positive individuals with a CD4 cell count more than 350…”
    Get full text
    Journal Article
  17. 17

    High prevalence of genotypic resistance to nucleoside reverse transcriptase inhibitors among therapy-naive individuals from the Warsaw cohort by HORBAN, A, STANCZAK, J. J, BAKOWSKA, E, TOBOLEWSKA, E. J, PRZYBYLSKA-STENGIEL, K. J, STANCZAK, G. P, BURKACKA, E

    Published in Infection (01-12-2002)
    “…The purpose of this study was to recognize nucleoside reverse transcriptase inhibitor (NRTI)-resistant HIV-1 strains among a group of therapy-naive patients,…”
    Get full text
    Journal Article
  18. 18

    Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy by BANNISTER, Wendy P, COZZI-LEPRI, Alessandro, PHILLIPS, Andrew, KJAER, Jesper, CLOTET, Bonaventura, LAZZARIN, Adriano, VIARD, Jean-Paul, KRONBORG, Gitte, DUICULESCU, Dan, BENIOWSKI, Marek, MACHALA, Ladislav

    Published in Journal of antimicrobial chemotherapy (01-04-2011)
    “…Estimating the prevalence of accumulated HIV drug resistance in patients receiving antiretroviral therapy (ART) is difficult due to lack of resistance testing…”
    Get full text
    Journal Article
  19. 19

    Fatal and non‐fatal AIDS and non‐AIDS events in HIV‐1 infected patients with high CD4 counts by Reekie, J, Gatell, J, Yust, I, Bakowska, E, Rachmanova, A, Losso, M, Krasnov, M, Francioli, P, Kowalska, J, Mocroft, A

    Published in Journal of the International AIDS Society (01-11-2010)
    “…7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK…”
    Get full text
    Journal Article
  20. 20